EPEkaterina Pivovarova

Ekaterina Pivovarova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ekaterina Pivovarova has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • An Experimental Survey of Key Factors Involved in Problem-Solving Court Staff Decisions About Medications For Opioid Use Disorder

    by M. H. Clark, Barbara Andraka-Christou, Jill Viglione, Ekaterina Pivovarova, Fatema Z. Ahmed, Danielle Atkins, Rachel Totaram, Brandon del Pozo

    Background: Medications for opioid use disorder (MOUD) are underused by problem-solving court (PSC) clients, despite their treatment efficacy. Prior qualitative work suggests PSC staff make case-by-case decisions about whether clients can use MOUD, with decisions influenced by the type of MOUD desired and the presence of PSC-MOUD provider partnerships. This study tests these qualitative findings using an experimental survey. Methods: A national convenience sample of 53 PSC staff was randomly assigned 8 of 32 hypothetical vignettes with varying court client factors in a factorial online survey experiment. For each vignette, staff were asked whether their court would allow MOUD. Decision factors tested included client race, client gender, type of MOUD, history of client MOUD misuse, and whether the MOUD would come from an MOUD provider who partners with the court. Client race and gender were made to vary across surveys, while the remaining factors varied within surveys. Hierarchical ordinal modeling tested the effects of factors on decisions. Results: PSC staff were significantly less likely ( P < .05) to allow MOUD if hypothetical clients (a) were prescribed methadone rather than buprenorphine, (b) desired medication from a non-partnering treatment provider versus a partner, or (c) had a history of MOUD misuse versus no history. Conclusion: Findings affirm prior qualitative work indicating the PSC’s relationship to the MOUD provider and MOUD type affect case-by-case PSC staff decisions about MOUD. Interventions to promote development of court-MOUD provider partnerships could help increase MOUD utilization among PSC clients. Partnerships with methadone providers might help address methadone misconceptions.

  • "So what's gonna happen when I get out of here?" Qualitative barriers and facilitators to MOUD continuity post-release from jail

    by Thomas J. Stopka, Rebecca E. Rottapel, Morgan Ruggiro, Claudia Santelices, Peter D. Friedmann, Ekaterina Pivovarova, Elizabeth A. Evans


  • Perspectives on collaboration between drug courts and MOUD providers: Impact of interagency implementation strategies

    by Ekaterina Pivovarova, Faye S. Taxman, Barbara Andraka-Christou, Alexandra Boland, Dara Drawbridge, David Smelson, Stephenie C. Lemon, Peter D. Friedmann

  • Open Access

    Perceived impacts of medications for opioid use disorder implementation on mental health services and substance use counseling in carceral settings: qualitative findings from 13 Massachusetts jails

    by Ekaterina Pivovarova, Peter D. Friedmann, Warren Ferguson, Benjamin J. Bovell Ammon, Thomas J. Stopka, Elizabeth A. Evans

    Background: Although research on Medications for Opioid Use Disorder (MOUD) in carceral settings has grown, it has largely focused on the implementation of medication delivery or on substance use outcomes in the community. However, the introduction of new programs or the expansion of treatment services in criminal legal settings can have both direct and indirect consequences on other treatment programs and correctional operations within jails. Mental health and substance use disorders frequently co-occur, and their psychosocial treatment components often overlap. We examined how the implementation of MOUD in all jails across Massachusetts impacted the mental health services operating within the jails and the requirements for substance use counseling alongside MOUD. Methods: We conducted semi-structured interviews ( n = 47) and focus groups ( n = 42) with staff from 13 county jails as part of an implementation of MOUD in jails study. Using deductive and inductive coding, all transcripts were double-coded and analyzed using a modified framework method. Results: We identified five key themes about the perceived impact of MOUD on mental health and substance use counseling services. First, MOUD implementation was perceived to reduce acute mental health crises, such as risk for suicide, and the demand on mental health services at intake to the facility. Second, staff perceptions about the effectiveness of MOUD as a stand-alone treatment influenced their decisions about the need for and interpretation of substance use counseling requirements. Third, the required components of substance use counseling created a need for additional staff, which exacerbated the existing shortage of mental health staff. Fourth, infrastructure limitations and privacy needs made the delivery of substance use counseling logistically challenging in jail settings. Finally, MOUD implementation increased interdisciplinary collaboration in some jails by requiring medical, mental health, and substance use providers to work together to resolve the needs of incarcerated individuals. Conclusions: As jails aim to meet regulatory requirements for MOUD, they will need to manage potential staffing shortages, infrastructure constraints, and shifts in the mental health and substance use counseling services. Guidelines for implementing MOUD in carceral settings should also consider the unintended consequences of MOUD on other behavioral health services.


  • Medication for Opioid Use Disorders (MOUD) Providers’ Experiences with Recovery Courts: Qualitative Study of Individual and Systemic Factors Impacting Interagency Collaboration

    by Ekaterina Pivovarova, Faye S. Taxman, Alexandra K. Boland, Barbara Andraka-Christou, Barbara A. De La Cruz, David Smelson, Stephenie C. Lemon, Peter D. Friedmann

    Background: Recovery courts mandate substance use disorder treatment as an alternative to prosecution or incarceration but lack internal resources to offer treatment. Hence, recovery courts must rely on community-based providers to ensure access to care. Interagency collaborations between recovery courts and providers of medications for opioid use disorders (MOUD) are often challenging. This qualitative study aimed to understand community-based MOUD providers’ perspectives on collaboration with recovery courts. Methods: Semi-structured, hourlong interviews were conducted with 24 providers from 11 community agencies about their experiences and perceptions of working with recovery courts. Consolidated Framework for Implementation Research informed study design, coding, and analysis. Results: At the individual-level domain, lack of knowledge about recovery courts and overall negative impressions of the criminal legal system were impediments to collaboration. Inner setting factors such as staffing shortages and provider roles in establishing therapeutic relationships limited active engagement in interagency collaboration. Outer setting domains such as communication barriers (eg, requirement of multiple release forms, lack of knowledge about who needed what information and when) and nonresponse from the courts were frequently referenced. Providers, however, also noted that direct experience with recovery court staff, especially in person, and recognition of mutual agency goals to ensure individuals receive proper care and remain in the community served as facilitators. Discussion: While interagency collaboration is essential to ensuring that individuals in recovery courts can access MOUD, providers identify individual- and system-level barriers that impact collaboration with recovery courts. Results from providers mirror findings from recovery court staff that note communication barriers, distrust toward external agencies, and limited resources for active collaboration. Findings highlight areas where implementation strategies to improve collaboration can be targeted to ensure that individuals in recovery courts can access and remain in MOUD treatment.


  • Collaborating With Jails to Provide Community-based Medication for Opioid Use Disorder: Qualitative Perspectives From MOUD Treatment Providers

    by Ekaterina Pivovarova, Bianca Y. Planas Garcia, Peter D. Friedmann, Thomas J. PhD Stopka, Claudia Santelices, Elizabeth A. PhD Evans

    Objectives: As carceral settings increasingly offer medications for opioid use disorders (MOUD), community-based providers will need to navigate relationships with correctional agencies to ensure continuity of MOUD upon release. Although collaboration has been identified as critical between agencies, limited research is available that details how providers can work with jails. We describe the perspectives of MOUD providers about their experiences collaborating with jails that had recently begun to offer MOUD. Methods: We conducted hour-long interviews with 36 MOUD providers from 18 community-based agencies. Exploration, Preparation, Implementation, and Sustainment (EPIS) concepts informed data collection and analysis. Results: MOUD providers described agency-specific (inner context) factors that facilitated collaboration, including staffing (employing staff with knowledge of co-occurring conditions) and agency culture (adaptability to change, recognition of gaps in services, being judgment-free). Providers also reported external factors as facilitators, such as broad community support of MOUD services and provision of training about MOUD to jail staff. Holding regular meetings, with a dedicated contact person, helped to overcome communication problems. However, the fragmentation of in-jail treatment services, exacerbated by jails’ contracting with different healthcare providers, made it difficult to coordinate re-entry and establish agency relationships. Actively and intentionally building interagency partnerships and collaborating across interagency cultural and structural differences were bridging factors that developed and sustained collaborations. Conclusions: Our findings offer promising suggestions for establishing collaborations with carceral partners, including assessing internal agency conditions, seeking external community supports, committing to actively engaging and sustaining collaborations, and using interagency differences to develop mutually beneficial relationships.


  • Open Access

    Factors affecting problem-solving court team decisions about medications for opioid use disorder

    by Barbara Andraka-Christou, Jill Viglione, Fatema Ahmed, Brandon del Pozo, Danielle N. Atkins, M.H. Clark, Rachel Totaram, Ekaterina Pivovarova


  • Facilitators and barriers to collaboration between drug courts and community-based medication for opioid use disorder providers

    by Ekaterina Pivovarova, Faye S. Taxman, Alexandra K. Boland, David A. Smelson, Stephenie C. Lemon, Peter D. Friedmann


  • Assessing feigning with the Feigning Evaluation INtegrating Sources (FEINS) in a forensic psychiatric sample.

    by Laura M. Grossi, Debbie Green, Mollimichelle Cabeldue, Ekaterina Pivovarova

    Evaluators of examinees in forensic contexts must consider the potential for falsified or exaggerated psychiatric symptoms and/or cognitive deficits. A number of validated assessment tools assist evaluators in identifying those examinees who feign impairment; however, no comprehensive method has been established for consolidating data from multiple tests, interviews, behavioral observations, and collateral sources. The current pilot study preliminarily examined the interrater reliability and validity of a new forensic assessment tool, the Feigning Evaluation INtegrating Sources (FEINS), developed to guide evaluators in the comprehensive assessment of feigning by adding structure to the collection of relevant data. Fifty-eight male pretrial defendants undergoing restoration of competency to stand trial at a state forensic psychiatric center participated in the study. Results provided preliminary support for reliability in scoring the FEINS, construct validity, and predictive validity. FEINS items that assessed clinical presentation, and those that guided the use of test data, were more useful than items capturing historical/demographic data. Structured professional judgments developed using the FEINS appeared to be more accurate in predicting competency evaluators' perceptions of feigning than both unstructured clinical judgment (i.e., referring psychologist's perception of feigning) alone and test data alone, using hierarchical multiple regressions. Findings suggest that the FEINS may have practical utility in guiding clinical opinions regarding feigning across psychiatric, cognitive, and psycholegal/functional domains. (PsycInfo Database Record (c) 2020 APA, all rights reserved).